This would significantly reduce the progression of kidney disease among the population.
. It has been stable in those with Type 1 diabetes and Type 2 diabetes in residents aged 50-80.
Several other studies from around the globe support this finding which was published in the American Journal of Kidney Diseases
. In addition to this, the team also arrived at the following conclusions:
- Incidence of end-stage kidney disease was found to be higher in men than in women
- The occurrence of ESKD was higher in those from most disadvantaged areas
- ESKD was more common in indigenous people compared to non-indigenous people
- Similarly, it was higher in people living in remote areas as opposed to those from major cities
The Way Forward
End-stage kidney disease
occurs when the kidneys are unable to function normally leading to the buildup of waste and excess fluids which otherwise would be excreted. When the kidneys fail to do so, dialysis and transplantation would be required to sustain the patients.
Diabetes has been identified as the primary cause for ESKD
and is accountable for over 40 percent of newly reported cases of kidney failure in most developed countries. The patients could experience a wide range of symptoms including nausea, loss of appetite, fatigue, sleep problems, and muscle cramps.
Professor Jonathan Shaw, a senior author, diabetes researcher and endocrinologist from the Baker Institute has made a critical observation in this context. Owing to the increased prevalence of diabetes, in addition, to the rise in incidence of EKSD in Type 2 diabetes patients, the Australian healthcare system is bound to find itself burdened with increased demand for dialysis and transplantation services.
Prof Shaw was quoted saying, "We've known for a long time that the total number of people requiring kidney dialysis or transplantation in Australia was going up but we thought that was mainly due to increasing numbers of people with diabetes."
He also added that "The main concern is the increasing rate in the under the 50s. This is a really troubling finding but hopefully, by improving medical care, by aggressively managing blood pressure and other cardiovascular risk factors in addition to blood sugar control, we can start to turn this around."
In conclusion, Prof Shaw mentioned that it remained uncertain if the present scenario in Australia is an indication of the less aggressive medical therapy that has been used to treat Type 2 diabetes patients over the past 12 years or the way kidney diseases have been managed so far. There is also the possibility of the emergence of a new aggressive form of the disease which calls for further research in this area to understand the implications clearly. Reference :
- Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013 - (http://dx.doi.org/10.1053/j.ajkd.2018.10.005)